Salmon Peptides vs Whey: +13% Ferritin in 8 Weeks (14-Person Pilot)
A small Norwegian trial found that 12 g/day of salmon protein hydrolysate lifted ferritin by about 13% and red blood cells by about 7% compared with whey over eight weeks. Secondary results hinted at lower inflammation, better glucose markers and improved body composition. But the study had only 14 participants and was industry-sponsored, so it is a signal rather than proof. Here is what salmon peptides are, what the trial found, how they differ from collagen, and why caution is essential.
NR + Pterostilbene Lifts NAD+ ~40–90% in Human Trial
Can a daily capsule of nicotinamide riboside and pterostilbene raise NAD+ in older adults? In the first-in-human NRPT (Basis) trial, 120 people aged 60 to 80 took it for eight weeks. Blood NAD+ rose about 40% at the recommended dose and about 90% at double the dose, and the rise held steady through the study. No serious adverse events were reported. Here is what the numbers show, what the dose takeaways are, and what the study cannot tell you.
Spermidine for Memory? A 12-Month Trial in 100 Older Adults Found No Edge Over Placebo
Spermidine has been hyped as a brain-protecting supplement on the strength of autophagy research and animal studies. The SmartAge trial put it to a rigorous test in 100 older adults with subjective cognitive decline, giving about 0.9 mg per day for 12 months. The primary memory outcome did not beat placebo (difference -0.03; P = .47), and secondary outcomes were also null. Exploratory hints on inflammation and verbal memory remain unconfirmed. Here is what the result means for anyone considering a spermidine supplement, and where the study's limits lie.
1,000 mg of Nicotinamide Riboside Daily Raised Blood Cell NAD+ by About 60% in Older Adults, Randomized Trial Finds
A 2018 Nature Communications crossover trial tested nicotinamide riboside at 500 mg twice daily (1,000 mg/day) for six weeks in healthy middle-aged and older adults. The supplement was well tolerated and raised NAD+ in blood immune cells by about 60% compared with placebo. Researchers also saw early signals for lower blood pressure and arterial stiffness, which they flagged as ideas for larger trials, not proven benefits. This article explains why NAD+ is thought to fall with age, what the study did, and what it cannot tell us about disease outcomes or longevity.
Urolithin A, the Pomegranate Postbiotic, Triggers a Mitophagy Signature in Older Adults
Urolithin A, a molecule made by gut bacteria from pomegranate and walnut polyphenols, has long rejuvenated muscle in aging animals. The first human trial in older adults found it safe, bioavailable, and able to shift mitochondrial biomarkers at 500 to 1,000 mg a day. The study, backed by the company behind Mitopure, showed a molecular signature of improved mitochondrial health in muscle. But it was small, short, and measured biomarkers rather than strength or longevity. Here is what the data show, who it is aimed at, and where the evidence stops.